PT724634E - Metodo para a marcacao de celulas eucarioticas por meio da utilizacao de um receptor da superficie da celula como um marcador - Google Patents

Metodo para a marcacao de celulas eucarioticas por meio da utilizacao de um receptor da superficie da celula como um marcador

Info

Publication number
PT724634E
PT724634E PT94926187T PT94926187T PT724634E PT 724634 E PT724634 E PT 724634E PT 94926187 T PT94926187 T PT 94926187T PT 94926187 T PT94926187 T PT 94926187T PT 724634 E PT724634 E PT 724634E
Authority
PT
Portugal
Prior art keywords
receptor
pct
cell surface
marking
nucleic acid
Prior art date
Application number
PT94926187T
Other languages
English (en)
Inventor
Claudio Bordignon
Fulvio Mavilio
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11401929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT724634(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of PT724634E publication Critical patent/PT724634E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
PT94926187T 1993-09-01 1994-08-11 Metodo para a marcacao de celulas eucarioticas por meio da utilizacao de um receptor da superficie da celula como um marcador PT724634E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930587A IT1261847B (it) 1993-09-01 1993-09-01 Metodo per marcare cellule eucariote.

Publications (1)

Publication Number Publication Date
PT724634E true PT724634E (pt) 2004-03-31

Family

ID=11401929

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94926187T PT724634E (pt) 1993-09-01 1994-08-11 Metodo para a marcacao de celulas eucarioticas por meio da utilizacao de um receptor da superficie da celula como um marcador

Country Status (12)

Country Link
US (1) US6074836A (pt)
EP (1) EP0724634B1 (pt)
JP (1) JP2781276B2 (pt)
AT (1) ATE254660T1 (pt)
CA (1) CA2170757C (pt)
DE (1) DE69433342T2 (pt)
DK (1) DK0724634T3 (pt)
ES (1) ES2210260T3 (pt)
IL (2) IL110815A0 (pt)
IT (1) IT1261847B (pt)
PT (1) PT724634E (pt)
WO (1) WO1995006723A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19643682C1 (de) * 1996-10-23 1998-01-15 Manfred Prof Dr Gareis Verfahren zum Herkunftsnachweis von Nutztieren sowie davon stammenden Produkten
US6500421B1 (en) * 1996-11-04 2002-12-31 St. Jude Children's Research Hospital In vivo selection of primitive hematopoietic cells
EP0972829A4 (en) * 1997-01-31 2001-01-03 Dnavec Research Inc ANIMALS WITH GENE INACTIVATION
ES2232845T3 (es) * 1997-08-22 2005-06-01 Science Park Raf S.P.A. Vacunacion tumoral mediante la utilizacion de celulas autologas o celulas presentadoras de antigeno (apc) relacionadas con hla transducidas con un antigeno tumoral y un antigeno ajeno capaz de producir una reaccion inmune.
ZA989497B (en) * 1997-10-20 2000-04-19 Roche Diagnostics Gmbh Positive-negative selection in homologous recombination.
IT1297016B1 (it) * 1997-12-23 1999-08-03 San Raffaele Centro Fond Processo di selezione di linfociti t cd4+ per la transduzione di geni anti-hiv
IT1312570B1 (it) * 1999-05-28 2002-04-22 Genera Spa Metodo per il traferimento di antigeni a cellule dendritiche.
EP1278773A2 (en) * 1999-11-19 2003-01-29 Novartis AG Selectable cell surface marker genes
US6790614B1 (en) 1999-11-19 2004-09-14 Novartis Ag Selectable cell surface marker genes
JP2003533183A (ja) * 2000-03-30 2003-11-11 ノバルティス アクチエンゲゼルシャフト 選択マーカー遺伝子
DE10019075B4 (de) * 2000-04-18 2007-01-18 Vision 7 Gmbh Verwendung von CD34 oder einem davon abgeleiteten Polypeptid als Zell-Oberflächen- bzw. Gentransfer-Marker
WO2002097059A2 (en) * 2001-05-30 2002-12-05 Chromos Molecular Systems, Inc. Chromosome-based platforms
US7737124B2 (en) 2001-09-13 2010-06-15 California Institute Of Technology Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
US7919309B2 (en) 2001-09-13 2011-04-05 California Institute Of Technology Method for expression of small antiviral RNA molecules within a cell
CN1780920B (zh) * 2003-05-12 2012-03-28 波多玛克制药有限公司 基因表达抑制剂
GB0413702D0 (en) 2004-06-18 2004-07-21 Molmed Spa Thymidine kinase
US8828727B2 (en) 2004-07-21 2014-09-09 Dana-Farber Cancer Institute Lentiviral vectors and uses thereof
WO2013050523A1 (en) 2011-10-05 2013-04-11 Molmed Spa Viral vectors purification system
US20140037599A1 (en) * 2012-08-03 2014-02-06 The Trustees Of The University Of Pennsylvania Compositions and Methods of Treating T Cell Deficiency

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055459A (en) * 1986-06-30 1991-10-08 Board Of Regents, The University Of Texas Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates
WO1991016069A1 (en) * 1990-04-17 1991-10-31 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Selective cytotoxic reagents comprising toxic moieties derived from mammalian proteins
CA2040099A1 (en) * 1990-05-01 1991-11-02 Mariano Barbacid Tyrosine kinase negative trkb
US5462856A (en) * 1990-07-19 1995-10-31 Bunsen Rush Laboratories, Inc. Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
ES2080341T3 (es) * 1990-09-14 1996-02-01 Univ Johns Hopkins Metodos y composiciones para la terapia genetica y la potenciacion de la inmunidad antitumoral.
US5470730A (en) * 1990-09-28 1995-11-28 Immunex Method for producing TH -independent cytotoxic T lymphocytes
EP0557459B1 (en) * 1990-11-13 1997-10-22 Immunex Corporation Bifunctional selectable fusion genes
AU9164991A (en) * 1990-11-30 1992-06-25 Abbott Laboratories Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor
AU1922092A (en) * 1991-05-03 1992-12-21 Albert Einstein College Of Medicine Of Yeshiva University Targeted delivery of genes encoding cell surface receptors
US5529774A (en) * 1991-08-13 1996-06-25 The Regents Of The University Of California In vivo transfer of the HSV-TK gene implanted retroviral producer cells
JP2006344159A (ja) * 2005-06-10 2006-12-21 Toshiba Information Systems (Japan) Corp 共通バス接続デバイス用通信制御装置

Also Published As

Publication number Publication date
US6074836A (en) 2000-06-13
WO1995006723A1 (en) 1995-03-09
ITRM930587A0 (it) 1993-09-01
DK0724634T3 (da) 2004-03-29
IL110815A0 (en) 1994-11-11
JP2781276B2 (ja) 1998-07-30
CA2170757C (en) 2003-04-22
DE69433342D1 (de) 2003-12-24
IT1261847B (it) 1996-06-03
IL147557A (en) 2006-10-31
DE69433342T2 (de) 2004-09-09
EP0724634B1 (en) 2003-11-19
ITRM930587A1 (it) 1995-03-01
ES2210260T3 (es) 2004-07-01
EP0724634A1 (en) 1996-08-07
JPH09501569A (ja) 1997-02-18
CA2170757A1 (en) 1995-03-09
ATE254660T1 (de) 2003-12-15

Similar Documents

Publication Publication Date Title
PT724634E (pt) Metodo para a marcacao de celulas eucarioticas por meio da utilizacao de um receptor da superficie da celula como um marcador
Bittner et al. Isolated light chains of botulinum neurotoxins inhibit exocytosis: studies in digitonin-permeabilized chromaffin cells
UA74325C2 (uk) ГЕТЕРОЦИКЛІЧНІ ІНГІБІТОРИ р38, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЇХ МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ ЗА ЇХ ДОПОМОГОЮ
DE69808274D1 (de) Kombinationsprodukt, enthaltend eine nukleinsäure und eine substanz, die die extrazellulärematrix desorganisiert, zur verwendung in gentherapie
Field et al. Refining instrument attachment on phocid seals.
DE69830404D1 (de) P38-inhibitoren
DE69724241D1 (de) Gdnf-rezeptor und dessen verwendung
DE69939864D1 (de) Ppar-gamma modulatoren
BR0007487A (pt) Difenil-uréias substituìdas com w-carbóxi-arilas como inibidores de raf cinase
BR9714415A (pt) Heterociclos contendo nitrogênio substituìdo como inibidores de proteìnas quinase p38
BRPI0507776A (pt) métodos de modular a atividade de citocina; reagentes relacionados
DE69635924D1 (de) Isolierung und züchtung von schwannzellen
DE69429011D1 (de) Ein verfahren zum sensibilisieren von krebszellen zur durch killer-zellen vermittelte lyse
ATE458497T1 (de) Antagonisten von 'hedgehog' und 'patched' zur inhibierung des wachstums und der differenzierung von zellen und geweben, als auch deren verwendungen
PT851926E (pt) Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada
Brzin The localization of acetylcholinesterase in axonal membranes of frog nerve fibers.
BR9306650A (pt) Processo para a polimerização e/ou modificação enzimática de lignina ou de material contendo lignina por meio do tratamento com uma peroxidase uso do processo e cola ou agente aglutinante ativo
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
Fassini et al. The reaction of the sponge Chondrosia reniformis to mechanical stimulation is mediated by the outer epithelium and the release of stiffening factor (s)
BR112022018657A2 (pt) Anticorpos, ácido nucleico, célula hospedeira, imunoconjugado, formulação farmacêutica, usos de um anticorpo, métodos de produção de um anticorpo e de tratamento de um indivíduo, métodos para inibir a sinalização de smad e para diagnosticar um indivíduo como tendo ssc e kit
ATE203772T1 (de) Markiergen
ZA985090B (en) CNS neuroregenerative compositions and methods of use
WO1999049876A3 (en) Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof
ATE191223T1 (de) Verwendung von zelladhäsions-peptiden zur modifikation des haftungsvermögens eukaryontischer zellen untereinander
AP2368A (en) Novel expression vectors and uses thereof.